FemHealth for Clinicians

Women have been systematically underrepresented in clinical trials for decades. Many landmark studies that inform current guidelines enrolled fewer than 20% female participants and did not report outcomes stratified by sex. FemHealth surfaces this information directly in search results - without opening a paper.

What Clinicians Use FemHealth For

• Assessing whether a trial's evidence is applicable to female patients before citing it
• Identifying explicit exclusion criteria (pregnancy, breastfeeding, childbearing age) at a glance
• Finding active ClinicalTrials.gov trials with sex eligibility data for patient referrals
• Understanding whether clinical guidelines were built on representative evidence

Sex-Equity Signals in Every Result

Every FemHealth result card shows: the proportion of female participants (where reported), any detected exclusion criteria (pregnancy excluded, breastfeeding excluded, males only), ClinicalTrials.gov phase and enrolment status, and open access availability. All of this is visible before you open the paper.

Databases Searched

FemHealth searches PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov simultaneously on every query. Ten additional sources are available via opt-in toggles including preprints, SciELO, WHO publications, CORE, OpenAIRE, Semantic Scholar, and six traditional medicine corpora.

Methodology

The Methodology page describes exactly how sex-equity signals are calculated - including known limitations such as publisher-restricted abstracts where extraction is not possible.

Free during beta. No account required. Search now →